Scholar Rock (SRRK) stock gains as Bank of America launches its coverage with a Buy recommendation, citing a blockbuster potential for its lead drug. Read more here.
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...